Is Solesence, Inc. Common Stock (SLSN) a Buy, Sell, or Hold?
NASDAQ : SLSN
Solesence, Inc. Common Stock — News
$1.035 USD
-$0.04 (-3.27%)
- Volume
- 40.36K
- Average Volume
- 85.63K
- Market Capitalization
- $73.1M
- P/E Ratio
- 67.65
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.55
- Year Low
- $0.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.08
| Source | Headline |
|---|---|
|
Solésence Reschedules Second Quarter 2026 Conference Call to August 19
ROMEOVILLE, Ill. , Aug. 10, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company has rescheduled its second quarter 2026 conference call and webcast. globenewswire.com - 2026-08-10 18:15:00 |
|
Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date. globenewswire.com - 2026-07-28 16:10:00 |
|
SLSN Unveils Two Scalp Care Products Using Patented Technology
Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection. zacks.com - 2026-07-14 12:51:09 |
|
Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen globenewswire.com - 2026-07-13 08:30:00 |
|
Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. globenewswire.com - 2026-06-18 15:49:00 |
|
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
SPF-Infused Concealer Featuring Kleair, WHSPR, and Chromalüm Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin ROMEOVILLE, Ill. , May 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that its prototype product, Day Mode Hero Concealer SPF 50, has won across three prototype product/chassis categories at the 2026 Cosmetics and Toiletries (C&T) Allē Awards: Anti-Aging, Color Cosmetics, and Compromised Skin. globenewswire.com - 2026-05-19 15:31:49 |
|
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin globenewswire.com - 2026-05-19 15:31:00 |
|
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs
Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin improves and the company reaffirms its 2026 profitability targets. zacks.com - 2026-05-19 14:50:10 |
|
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation. globenewswire.com - 2026-05-14 18:00:00 |
|
Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript
Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-12 14:10:52 |
|
Solésence Reports First Quarter 2026 Financial Results
Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026. globenewswire.com - 2026-05-12 08:00:00 |
|
Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™
New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment globenewswire.com - 2026-05-11 09:00:00 |
